Chengdu Wision Medical Device
About Chengdu Wision Medical Device
Chengdu Wision Medical Device, also known as Wision A.I., is a healthcare AI company focused on transforming clinical practice through digital health innovations. They specialize in developing computer-aided diagnosis (CAD) algorithms and systems for clinical imaging to improve diagnostic accuracy and effectiveness. Their flagship product, EndoScreener, is an AI-powered software designed for real-time automatic detection of polyps during colonoscopy procedures. It processes live video feeds from colonoscopes and overlays visual alerts on suspected polyps, aiming to enhance polyp detection and support clinical decision-making for endoscopists.
Wision A.I. integrates medical knowledge into scalable models using advanced convolutional neural networks. The EndoScreener has received regulatory clearances, including FDA 510(k) clearance in November 2021 and CE Mark Class II approval under the new Medical Devices Regulation (MDR 2017/745) in November 2021. Clinical studies have demonstrated its efficacy in improving adenoma detection rates. Beyond gastrointestinal endoscopy, Wision A.I. is also involved in histopathology, with efforts in whole slide localization of cancerous regions in Whole Slide Imaging (WSI).
Focus Areas
Business Intelligence
| Technology | Cloud-native AI platform, deep learning algorithms for real-time image analysis |
What Physicians Need to Know
For physicians, Chengdu Wision Medical Device's EndoScreener offers real-time AI-assisted polyp detection during colonoscopies, providing visual and audible alerts that can significantly improve adenoma detection rates and reduce the miss rate of precancerous lesions. The software is compatible with most mainstream endoscope systems, allowing for flexible integration into existing clinical workflows. While the AI assists in identification, physicians remain responsible for confirming findings based on their medical judgment. Their histopathology tools, like PathoCruz 3D, are designed to enhance diagnostic precision by providing 3D renderings of tissue samples, offering a more comprehensive view of tumors. This can aid in personalized treatment plans and automate post-procedure pathological assessments.
The EndoScreener is a software-only medical device (SaMD) compatible with most mainstream endoscope systems, allowing for flexible deployment and seamless integration into current clinical workflows. It processes live video feed from the colonoscope and overlays blue boxes on suspected polyps. The system can be deployed with appropriate hardware in mainstream computers.
What the Web Says
Chengdu Wision Medical Device Co., Ltd. is a healthcare AI company that develops gastroenterology AI tools for physicians, with a focus on computer-aided detection software for colorectal polyps. Their product, EndoScreener, is designed to assist physicians in real-time identification of suspect polyps during colonoscopies. The company's products have received marketing approval in China and FDA clearance in the United States. While there is information available on their product's efficacy and regulatory status, there is limited public information regarding employer reviews or general company sentiment outside of product performance.
Overall: MixedStrengths
- Computer-aided detection of colorectal polyps
- Assists physicians in real-time during colonoscopies
- Utilizes deep learning models for high performance
- Approved for marketing in China
- FDA cleared in the United States
- Potential for earlier detection of precancerous lesions
Limitations
- Limited information on employer or general company reviews
- Product not intended for diagnosis or characterization of lesions
- Does not replace clinical decision-making
- Morphological evidence alone may not reveal molecular causes of illnesses
Based on reviews from: Physician AI Tools, NMPA (China National Medical Products Administration), PubMed Central, Innolitics, accessdata.fda.gov, HealthAidb — Software
Last updated: 2026-10-19
Videos
News, demos, and interviews about Chengdu Wision Medical Device.
Videos load interactively. If none appear, search YouTube for Chengdu Wision Medical Device →
Press & Coverage
Frequently Asked Questions
Related Companies
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]
Cosmo Artificial Intelligence (Cosmo AI) is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. The company focuses on developing and manufacturing innovative, high-quality products and technologies, particularly those supported by AI and digital health, to enhance healthcare delivery. Cosmo AI’s mission is to empower patients, healthcare professionals, and partners by innovating at […]
Exact Sciences is a molecular diagnostics company dedicated to the early detection and prevention of cancer, as well as guiding treatment decisions. The company is best known for its non-invasive colorectal cancer screening test, Cologuard, which analyzes stool samples for DNA markers and occult hemoglobin to assess a patient’s risk of colorectal cancer. Cologuard was […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]
Motus GI Holdings, Inc. is a medical technology company that develops innovative solutions for gastrointestinal procedures, primarily focusing on enhancing colonoscopy outcomes. Their flagship product, the Pure-Vu System, is a U.S. FDA-cleared and CE-marked medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy procedures. The […]
Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio […]